HCA Healthcare, Inc. $HCA Stock: Wellington Grp LLC Increases Holdings

Wellington Grp LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 51.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,303 shares of the company’s stock after acquiring an additional 1,122 shares during the quarter. Wellington Grp LLC’s holdings in HCA Healthcare were worth $1,410,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of HCA. MidFirst Bank purchased a new position in HCA Healthcare in the second quarter valued at about $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare during the 2nd quarter worth approximately $29,000. Latitude Advisors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $32,000. Delos Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $35,000. Finally, Laurel Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $40,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.0%

Shares of HCA Healthcare stock opened at $498.82 on Monday. The business has a fifty day simple moving average of $452.79 and a 200-day simple moving average of $445.91. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm has a market cap of $104.20 billion, a price-to-earnings ratio of 16.53, a price-to-earnings-growth ratio of 1.67 and a beta of 1.11.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm had revenue of $19.85 billion for the quarter, compared to analyst estimates of $19.33 billion. During the same period in the previous year, the company earned $6.96 earnings per share. HCA Healthcare’s revenue was up 3.6% compared to the same quarter last year. Analysts anticipate that HCA Healthcare, Inc. will post 30.14 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s payout ratio is presently 10.34%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on HCA shares. Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $381.00 to $468.00 and gave the company an “equal weight” rating in a research note on Monday, November 2nd. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. UBS Group dropped their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. The Goldman Sachs Group reduced their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday, July 28th. Finally, Barclays increased their price objective on shares of HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a report on Thursday, October 29th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $480.13.

Read Our Latest Stock Report on HCA

Insider Buying and Selling

In related news, COO Jon Foster sold 21,713 shares of the stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the sale, the chief operating officer directly owned 10,000 shares of the company’s stock, valued at $4,949,500. This represents a 68.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Schlosser sold 1,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total transaction of $593,580.00. Following the sale, the executive vice president owned 1,443 shares of the company’s stock, valued at $713,779.95. The trade was a 45.40% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 36,413 shares of company stock worth $18,251,464 in the last ninety days. 1.50% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.